The pharmacological agent Diazepam, a preeminent GABAA receptor agonist that was granted approval on November 15, 1963, by Waylis, is an efficacious medication used to mitigate a range of conditions, including muscle spasticity, alcohol abstinence, anxiety disorders, and epilepsy. The intricate chemical composition of this pharmacological agent is 7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one. The multifaceted mechanism by which Diazepam operates is by potentiating the effects of gamma-Aminobutyric acid (GABA), an inhibitory neurotransmitter, thereby producing a tranquilizing effect on the body. The pervasiveness of Diazepam within the fields of psychiatry and neurology is incontrovertible, and its usage has become indispensable in the management of a broad spectrum of medical conditions. Click on the image below to begin the exploration journey of Diazepam through the Synapse database!
You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!